Patients with NF-PanNET-G1 have a very low risk of pN+ in the absence of radiological signs of node involvement. When preoperative grading assessment is not achieved, the radiological size of the lesion is a powerful alternative predictor of pN+. The risk of pathological nodal involvement in patients with NF-PanNETs can be accurately estimated by a clinical predictive model.
In selected patients, with small and low-grade tumors, PSP are associated with excellent overall and recurrence-free survivals. These procedures are associated with an increased postoperative morbidity but an excellent postoperative pancreatic function. Therefore, they should be considered as a valid therapeutic option in selected well-differentiated pancreatic neuroendocrine tumors.
We describe an experiment in which a train of femtosecond pulses is coupled into a photonic crystal fiber (PCF) by means of an offset pumping technique that can selectively excite either the mode LP(01) or LP(11) or LP(21). The PCF presents a wide range of wavelengths in which the fundamental mode experiences normal dispersion, whereas LP(11) and LP(21) propagate in the anomalous dispersion regime, generating a supercontinuum based on the soliton fission mechanism. We find that the existence of a cut-off wavelength for the higher-order modes makes the spectral broadening asymmetrical. This latter effect is particularly dramatic in the case of the LP(21) mode, in which, by using a pump wavelength slightly below cut-off, the spectral broadening occurs only on the blue side of the pump wavelength. Our experimental results are successfully compared to numerical solutions of the nonlinear Schrödinger equation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.